Jonathan Yong
Stock Analyst at UBS
(2.64)
# 1,706
Out of 5,182 analysts
95
Total ratings
61.11%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $17.18 | -1.05% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $1.76 | +184.09% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.52 | +19.05% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $13.74 | -12.66% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.28 | +250.88% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $10.30 | +152.43% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $29.39 | -52.36% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $77.20 | +24.35% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $16.45 | +94.53% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $20.98 | +400.48% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $100.92 | -20.73% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $263.43 | -12.31% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $5.85 | +361.54% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $202.34 | -50.58% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $828.32 | -45.67% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $1.01 | +1,088.12% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $6.14 | +1,040.07% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $21.70 | -21.66% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $179.22 | +95.29% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $28.15 | +237.48% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $1.17 | +626.50% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $24.41 | +67.96% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.81 | +202.49% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $86.30 | -1.51% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $196.63 | -25.75% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $43.50 | +143.68% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $179.51 | -12.54% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $282.58 | +30.23% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $223.62 | +183.96% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $78.36 | +49.31% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $23.39 | +28.26% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $445.77 | -33.15% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $185.53 | -48.80% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $354.69 | +39.56% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $17.18
Upside: -1.05%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $1.76
Upside: +184.09%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.52
Upside: +19.05%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $13.74
Upside: -12.66%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.28
Upside: +250.88%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $10.30
Upside: +152.43%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $29.39
Upside: -52.36%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $77.20
Upside: +24.35%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $16.45
Upside: +94.53%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $20.98
Upside: +400.48%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $100.92
Upside: -20.73%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $263.43
Upside: -12.31%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $5.85
Upside: +361.54%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $202.34
Upside: -50.58%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $828.32
Upside: -45.67%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $1.01
Upside: +1,088.12%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $6.14
Upside: +1,040.07%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $21.70
Upside: -21.66%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $179.22
Upside: +95.29%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $28.15
Upside: +237.48%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $1.17
Upside: +626.50%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $24.41
Upside: +67.96%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.81
Upside: +202.49%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $86.30
Upside: -1.51%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $196.63
Upside: -25.75%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $43.50
Upside: +143.68%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $179.51
Upside: -12.54%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $282.58
Upside: +30.23%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $223.62
Upside: +183.96%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $78.36
Upside: +49.31%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $23.39
Upside: +28.26%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $445.77
Upside: -33.15%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $185.53
Upside: -48.80%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $354.69
Upside: +39.56%